Medtronic buys embolic protection device company PercuSurge
This article was originally published in Clinica
Executive Summary
Medtronic is to speed up attempts to get an embolic protection device onto the US market by buying private company PercuSurge for $225 million in a stock swap. PercuSurge's device, which traps debris following interventional procedures, could be approved by the FDA in the second quarter of next year, while Medtronic's own development-stage product is not expected to reach the market before 2003.